Journal of diabetes investigation

Keyphrases

Publications

volume 15, number 9, 2024

Kai Zhang, Yunyi Li, Xiao Ge, Linlin Meng, Jing Kong, Xiao Meng
Regulatory T cells protect against diabetic cardiomyopathy in db/db mice. Journal of diabetes investigation 15 (9) (2024)
Joonyub Lee, Kun-Ho Yoon
Islet transplantation in Korea. Journal of diabetes investigation 15 (9) (2024)
Tetsuaki Inokuchi, Yoshihide Fukumoto, Gendai Lee, Yoshifumi Yokomizo, Kokichi Tanaka, Michiko Chosa, Masaru Doi, Noboru Tamaki, Seiichi Goto, Kojiro Ichikawa, Kazuo Kobayashi
Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics. Journal of diabetes investigation 15 (9) (2024)
Ryotaro Bouchi, Kazuo Izumi, Naoki Ishizuka, Yukari Uemura, Hiroshi Ohtsu, Kengo Miyo, Shigeho Tanaka, Noriko Satoh-Asahara, Kazuo Hara, Masato Odawara, Yoshiki Kusunoki, Hidenori Koyama, Takeshi Onoue, Hiroshi Arima, Kazuyo Tsushita, Hirotaka Watada, Takashi Kadowaki, Kohjiro Ueki
Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial. Journal of diabetes investigation 15 (9) (2024)
Juliana Chung Ngor Chan, Jean Claude Mbanya, Jean-Marc Chantelot, Marina Shestakova, Ambady Ramachandran, Hasan Ilkova, Lucille Deplante, Melissa Rollot, Lydie Melas-Melt, Juan Jose Gagliardino, Pablo Aschner
Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study. Journal of diabetes investigation 15 (9) (2024)
Ryotaro Bouchi, Tatsuya Kondo, Yasuharu Ohta, Atsushi Goto, Daisuke Tanaka, Hiroaki Satoh, Daisuke Yabe, Rimei Nishimura, Norio Harada, Hideki Kamiya, Ryo Suzuki, Toshimasa Yamauchi, null null
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes - 2nd edition (English version). Journal of diabetes investigation 15 (9) (2024)
Katsuhiko Hagi, Kenji Kochi, Hirotaka Watada, Kohei Kaku, Kohjiro Ueki
Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation 15 (9) (2024)
Daisuke Ito, Satoshi Shimizu, Akifumi Haisa, Shinnosuke Yanagisawa, Kazuyuki Inoue, Daigo Saito, Takashi Sumita, Morifumi Yanagisawa, Yoshihito Uchida, Kouichi Inukai, Akira Shimada
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD. Journal of diabetes investigation 15 (9) (2024)
Osamu Kikuchi, Yuichi Ikeuchi, Masaki Kobayashi, Yoko Tabei, Hiromi Yokota-Hashimoto, Tadahiro Kitamura
Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice. Journal of diabetes investigation 15 (9) (2024)
Ryoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Yoshiro Maezawa, Yuki Shiko, Yosuke Inaba, Yohei Kawasaki, Yusuke Kashiwagi, Eiryo Kawakami, Shuichi Yamamoto, Koutaro Yokote
Sodium-glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database. Journal of diabetes investigation 15 (9) (2024)
Katsuhiko Hagi, Kenji Kochi, Hirotaka Watada, Kohei Kaku, Kohjiro Ueki
Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation 15 (9) (2024)
Ryotaro Bouchi, Kazuo Izumi, Naoki Ishizuka, Yukari Uemura, Hiroshi Ohtsu, Kengo Miyo, Shigeho Tanaka, Noriko Satoh-Asahara, Kazuo Hara, Masato Odawara, Yoshiki Kusunoki, Hidenori Koyama, Takeshi Onoue, Hiroshi Arima, Kazuyo Tsushita, Hirotaka Watada, Takashi Kadowaki, Kohjiro Ueki
Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial. Journal of diabetes investigation 15 (9) (2024)
Daisuke Ito, Satoshi Shimizu, Akifumi Haisa, Shinnosuke Yanagisawa, Kazuyuki Inoue, Daigo Saito, Takashi Sumita, Morifumi Yanagisawa, Yoshihito Uchida, Kouichi Inukai, Akira Shimada
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD. Journal of diabetes investigation 15 (9) (2024)
Joonyub Lee, Kun-Ho Yoon
Islet transplantation in Korea. Journal of diabetes investigation 15 (9) (2024)
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation 15 (9) (2024)
Osamu Kikuchi, Yuichi Ikeuchi, Masaki Kobayashi, Yoko Tabei, Hiromi Yokota-Hashimoto, Tadahiro Kitamura
Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice. Journal of diabetes investigation 15 (9) (2024)
Mingxin Bai, Dawei Chen, Yan Liu, Xing-Wu Ran, Chun Wang, Lihong Chen, Donge Yan, Sen He, Murong Wu, Bo Luo, Wen Wang, Zhiyi Lei, Yun Gao
Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot. Journal of diabetes investigation 15 (9) (2024)
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation 15 (9) (2024)
Xingbo Cheng, Weiwei Liu, Ning Xu, Dong Yin, Ping Zheng, Guofeng Wang, Yuan Hui, Jiping Zhang, Guanjun Han, Chuanhui Yang, Yan Lu, Xingbo Cheng
Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case-control study. Journal of diabetes investigation 15 (9) (2024)
Jingyi Zhong, Xiaopu Lin, Xiaobin Zheng, Yanting Zhou, Haishan Huang, Ling-Ling Xu
Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients. Journal of diabetes investigation 15 (9) (2024)
Kai Zhang, Yunyi Li, Xiao Ge, Linlin Meng, Jing Kong, Xiao Meng
Regulatory T cells protect against diabetic cardiomyopathy in db/db mice. Journal of diabetes investigation 15 (9) (2024)
Mingxin Bai, Dawei Chen, Yan Liu, Xing-Wu Ran, Chun Wang, Lihong Chen, Donge Yan, Sen He, Murong Wu, Bo Luo, Wen Wang, Zhiyi Lei, Yun Gao
Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot. Journal of diabetes investigation 15 (9) (2024)
Grace Aprilia Helena, Shoen Kume
A sneak peek into chronic glucose exposure and insulin secretion impairment through translatome. Journal of diabetes investigation 15 (9) (2024)
Pannipa Suwannasom, Tasalak Thonghong, Krit Leemasawat, Teerapat Nantsupawat, Narawudt Prasertwitayakij, Chutamas Pairoj, Wanwarang Wongcharoen, Arintaya Phrommintikul, null null
Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus. Journal of diabetes investigation 15 (9) (2024)
Daisuke Ito, Satoshi Shimizu, Akifumi Haisa, Shinnosuke Yanagisawa, Kazuyuki Inoue, Daigo Saito, Takashi Sumita, Morifumi Yanagisawa, Yoshihito Uchida, Kouichi Inukai, Akira Shimada
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD. Journal of diabetes investigation 15 (9) (2024)
Juliana Chung Ngor Chan, Jean Claude Mbanya, Jean-Marc Chantelot, Marina Shestakova, Ambady Ramachandran, Hasan Ilkova, Lucille Deplante, Melissa Rollot, Lydie Melas-Melt, Juan Jose Gagliardino, Pablo Aschner
Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study. Journal of diabetes investigation 15 (9) (2024)
Tetsuaki Inokuchi, Yoshihide Fukumoto, Gendai Lee, Yoshifumi Yokomizo, Kokichi Tanaka, Michiko Chosa, Masaru Doi, Noboru Tamaki, Seiichi Goto, Kojiro Ichikawa, Kazuo Kobayashi
Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics. Journal of diabetes investigation 15 (9) (2024)
Mingxin Bai, Dawei Chen, Yan Liu, Xing-Wu Ran, Chun Wang, Lihong Chen, Donge Yan, Sen He, Murong Wu, Bo Luo, Wen Wang, Zhiyi Lei, Yun Gao
Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot. Journal of diabetes investigation 15 (9) (2024)
Pannipa Suwannasom, Tasalak Thonghong, Krit Leemasawat, Teerapat Nantsupawat, Narawudt Prasertwitayakij, Chutamas Pairoj, Wanwarang Wongcharoen, Arintaya Phrommintikul, null null
Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus. Journal of diabetes investigation 15 (9) (2024)
Ryoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Yoshiro Maezawa, Yuki Shiko, Yosuke Inaba, Yohei Kawasaki, Yusuke Kashiwagi, Eiryo Kawakami, Shuichi Yamamoto, Koutaro Yokote
Sodium-glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database. Journal of diabetes investigation 15 (9) (2024)
Junta Imai
Possible etiological role of impaired endogenous double strand RNA editing in β-cells in type 1 diabetes. Journal of diabetes investigation 15 (9) (2024)
Tetsuaki Inokuchi, Yoshihide Fukumoto, Gendai Lee, Yoshifumi Yokomizo, Kokichi Tanaka, Michiko Chosa, Masaru Doi, Noboru Tamaki, Seiichi Goto, Kojiro Ichikawa, Kazuo Kobayashi
Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics. Journal of diabetes investigation 15 (9) (2024)
Grace Aprilia Helena, Shoen Kume
A sneak peek into chronic glucose exposure and insulin secretion impairment through translatome. Journal of diabetes investigation 15 (9) (2024)
Osamu Kikuchi, Yuichi Ikeuchi, Masaki Kobayashi, Yoko Tabei, Hiromi Yokota-Hashimoto, Tadahiro Kitamura
Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice. Journal of diabetes investigation 15 (9) (2024)
Ryoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Yoshiro Maezawa, Yuki Shiko, Yosuke Inaba, Yohei Kawasaki, Yusuke Kashiwagi, Eiryo Kawakami, Shuichi Yamamoto, Koutaro Yokote
Sodium-glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database. Journal of diabetes investigation 15 (9) (2024)
Jingyi Zhong, Xiaopu Lin, Xiaobin Zheng, Yanting Zhou, Haishan Huang, Ling-Ling Xu
Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients. Journal of diabetes investigation 15 (9) (2024)
Juliana Chung Ngor Chan, Jean Claude Mbanya, Jean-Marc Chantelot, Marina Shestakova, Ambady Ramachandran, Hasan Ilkova, Lucille Deplante, Melissa Rollot, Lydie Melas-Melt, Juan Jose Gagliardino, Pablo Aschner
Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study. Journal of diabetes investigation 15 (9) (2024)
Naparat Sukkriang, Supawan Buranapin
Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial. Journal of diabetes investigation 15 (9) (2024)
Ryotaro Bouchi, Kazuo Izumi, Naoki Ishizuka, Yukari Uemura, Hiroshi Ohtsu, Kengo Miyo, Shigeho Tanaka, Noriko Satoh-Asahara, Kazuo Hara, Masato Odawara, Yoshiki Kusunoki, Hidenori Koyama, Takeshi Onoue, Hiroshi Arima, Kazuyo Tsushita, Hirotaka Watada, Takashi Kadowaki, Kohjiro Ueki
Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial. Journal of diabetes investigation 15 (9) (2024)
Pannipa Suwannasom, Tasalak Thonghong, Krit Leemasawat, Teerapat Nantsupawat, Narawudt Prasertwitayakij, Chutamas Pairoj, Wanwarang Wongcharoen, Arintaya Phrommintikul, null null
Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus. Journal of diabetes investigation 15 (9) (2024)
Junta Imai
Possible etiological role of impaired endogenous double strand RNA editing in β-cells in type 1 diabetes. Journal of diabetes investigation 15 (9) (2024)
Jingyi Zhong, Xiaopu Lin, Xiaobin Zheng, Yanting Zhou, Haishan Huang, Ling-Ling Xu
Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients. Journal of diabetes investigation 15 (9) (2024)
Xingbo Cheng, Weiwei Liu, Ning Xu, Dong Yin, Ping Zheng, Guofeng Wang, Yuan Hui, Jiping Zhang, Guanjun Han, Chuanhui Yang, Yan Lu, Xingbo Cheng
Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case-control study. Journal of diabetes investigation 15 (9) (2024)
Naparat Sukkriang, Supawan Buranapin
Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial. Journal of diabetes investigation 15 (9) (2024)
Naparat Sukkriang, Supawan Buranapin
Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial. Journal of diabetes investigation 15 (9) (2024)
Xingbo Cheng, Weiwei Liu, Ning Xu, Dong Yin, Ping Zheng, Guofeng Wang, Yuan Hui, Jiping Zhang, Guanjun Han, Chuanhui Yang, Yan Lu, Xingbo Cheng
Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case-control study. Journal of diabetes investigation 15 (9) (2024)
Ryotaro Bouchi, Tatsuya Kondo, Yasuharu Ohta, Atsushi Goto, Daisuke Tanaka, Hiroaki Satoh, Daisuke Yabe, Rimei Nishimura, Norio Harada, Hideki Kamiya, Ryo Suzuki, Toshimasa Yamauchi, null null
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes - 2nd edition (English version). Journal of diabetes investigation 15 (9) (2024)
Katsuhiko Hagi, Kenji Kochi, Hirotaka Watada, Kohei Kaku, Kohjiro Ueki
Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation 15 (9) (2024)
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation 15 (9) (2024)
Junta Imai
Possible etiological role of impaired endogenous double strand RNA editing in β-cells in type 1 diabetes. Journal of diabetes investigation 15 (9) (2024)